Esophageal cancer (EC) is a common malignant tumor in China, which is a type of malignant lesion formed by abnormal hyper­ plasia of esophageal squamous epithelium or glandular epitheli­ um with concealed onset. In the early stage, it is partly manifest­ ed as dysphagia, foreign body sensation in the esophagus or post-sternal burning. While in  the  middle and advanced  stages,  it would be manifested as a progressive dysphagia. The 2020 global cancer statistics showed that EC is the 8th most common malignant tumor in the world and the mortality rate is the sixth highest. Up to now, the treatment of EC is comprehensive char­ acterized by the radical surgery as the main therapy and radio­ therapy, chemotherapy, biological therapy as the complementary therapies. While surgery, radiotherapy and chemotherapy in­ creasingly exhibited their innate limitations and shortcomings in the treatment of EC, more and more attentions are casted on the traditional Chinese medicine (TCM)  especially  the combination of TCM and modern medicine with anticipation to overcome the shortcomings and improve the treatment ef 阮 acy. This review summarizes the elini('al research progress of TCM treatment for EC in the past 10 years and discusses how to recognize this dis­ ease in TCM.

[ 1 ] Smyth EC, Lagergren J, Fitzgerald RC, et al. Oe­ sophageal cancer. Nat Rev Dis Primers 2017; 3: 17048.

[ 2] Zheng DJ, Zhou ZX, Chen YY, et al. Zheng Wei­ da's experience in treating esophageal  cancer.  Clin J Chin Med 2015; 7: 1-3.

[3] ] Wang YP, Duan HR. Case  analysis  of treatment of esophageal cancer by du-meridian moxibus­ tion combined with chemotherapy. J Oneal Chin Med 2020; 2: 79-83.

[4] Wang YP, Li DK, Zhang YK, et al. Observation on the improvement effect of  du-moxibustion  on chemotherapy of esophageal cancer with qideficiency and stagnation. Clin J Tradit ChinMed 2022: 1113-7.

[ 7 ]Ye Z, Liu PM, Yu ZH. Treating advanced esopha­ geal cancer from "Wen yang fuzheng". Clin J Tra­ dit Chin Med 2022; 34: 413-7.

[8] He XR.  Research  on  the  effectiveness  of Qige  Powder combined   with   chemotherapy for the treatment of esophageal  cancer. Pract Clin ] In­ tegr Tradit Chin West Med 2021; 21: 41-2, 88.

[9] Dong ZM,  Wang  K,  Liu  J.  Clinical  study  on esophageal   cancer   treated    with esophageal pingsan combined with paclitaxel chemothera­ py. Clin J Tradit Chin Med 2021; 33: 1581-4.

[10] Song GH, Liu WQ, Chen W. S. Effect  of Shenqi

Guben Fuyuan Formula on  immune  function and nutritional status in patients undergone esophageal cancer radiotherapy with qi-blood deficiency. Hebei J Tradit Chin Med 2021; 43:

1092-6.

[11 ] Wang QT, Yang ZJ. Clinical study of  using San­ jie tongge decoction combined with convention­ al  chemotherapy   in  the  treatment of  advanced esophageal  cancer  interlegm  of tum mutual re­ sistance syndrome. ] Sichuan Tradit Chin Med 2021; 39: 85-8.

[12 ] Wang X, Chen Q, Zhu XY,  et  al.  Clinical effect of Yiqi Tiaozhong method combined with che­  motherapy in  the  treatment  of   middle and ad­  vanced  esophageal   cancer.   Oneal Prag 2021; 19: 1140-3.

[13]Sun C. Observation on the clinical  effect  of qige Huayu Powder combined with paclitaxel chemo­ therapy on esophageal cancer patients. Guang­ ming J Chin Med 2020; 35: 3610-2.

[14] Li JY. Clinical observation of Yipi Fuzheng Pre­

scription plus chemotherapy for the treatment of esophageal cancer in the middle and advanced stages. Guangming J Chin Med 2020; 35: 3630-3.

[23] ]Yang H, Wu X, Chu  RG. Discussion  on the appli­ cation of Xiaoqinglong Decoction for the treat­ ment of esophageal cancer. Guangming ] Chin Med 2022; 37: 507-9.

[24] Ren MM , Wang JY, Li L, et al. Discussion on syndrome differentiation and treatment of esoph­

ageal cancer based on the pathogenesis theory of cancer toxin. China J Tradit Chin Med Pharm 2022; 37: 839-42.

[ 10] Li J, Kong LY. Analysis on treating esophageal cancer with the method of moistening and nour­ ishing with sweet herbs. J Oncol Chin Med 2022; 4: 49-53.

[ 11] Zhang X, Han ST, Zhang QD. Professor Liu Shenlin's experience in treating esophageal cancer with traditional Chinese medicine. J Tianjin Univ Tradit Chin Med 2021; 40: 290-3.

[ 12] Duan HR, Liu PM. Application of "treating dis­ ease in the upper part of the body by  managing the lower" in treatment of esophageal  cancer. J Be 订 i ng Univ Tradit Chin Med 2021; 44: 188-

92.

[16] ]Zang YC, Xie QL, Zhang F,  et al.  Correlation of exogenous attack of wind-cold  and  internal in­ jury by cold fluid with esophageal cancer. J On­ colChinMed2020;2: 15-7.

[17] ]Jiang X, Tian YH, Zhang QL, et al.  HUANG Jin­ chang's experience in the treatment of esopha­ geal cancer. China J Tradit Chin Med Pharm 2020; 35: 203-5.

[ 15] Yu F, Fu X, You FM, et al. Discussion on the "toxicity" of esophageal cancer. Hubei ] Tradit Chin Med 2018; 40: 41-3.

[13] Liu WW, Qi YF. Qi Yuanfu's experience in treating esophageal cancer. Hunan J  Tradit Chin Med 2018; 34: 31-3.

[14] Pei K, Yang LY, Zhao YF, et al. Professor Qi Yuanfu's experience in syndrome differentiation and treatment of esophageal cancer. Hebei J Tradit  Chin Med  2017; 39: 815-8.

[15] ] Chen  JY,  Liu  TT,  Zhou  R,  et  al.  Analysis of prognostic factors  of   72   cases   of advanced esophageal cancer treated with traditional Chi­ nese medicine. J B 咐 ing Univ Tradit Chin Med 2022; 45: 446-51.

[16] ] Zhu XY, Wang KQ,  Zhang  CH,  et  al.  A retro­ spective study of 48 cases of esophageal cancer treated by Wang ke-Qiong with the original dose modification of major Pinellia decoction. Henan Tradit Chin Med 2021; 41: 1508-12.

[ 20] Wu YQ, Yu ZJ, Zhu JH. Summary of Professor Zhu Chunliang's experience in treating esopha­ geal cancer by the method of supplementing healthy qi and descending the reversal. ]  Yun­ nan Univ Tradit Chin Med 2016; 39: 84-7.

[ 21] Hu SB, Zhao MY, Zhang ZH. Clinical study on the effect of Chinese medicine decoction pieces combined with chemotherapy on early esopha­ geal cancer. Pract J Cancer 2022; 37: 611-4,

629.

[ 22 ] Li W. Qige Huayu Decoction in the treatment of patients with esophageal cancer due to intermin­ gling of phlegm and blood stasis in the middle and advanced stage. Pract Clin J Integr Tradit Chin West Med 2022; 22: 64-6.

[ 30 ] Wang TF, Zhang Z, Yao CS, et al. Analysis of prognosis of patients with esophageal cancer treated with Shashen Maimendong Decoction and DF regimen. Chin J lntegr Tradit West Med Dig 2019; 27: 119- 21, 127.

[ 31 ] Xin LY, Sun YP. Influence of traditional Chi­ nese medicine emotional intervention  on quali­ ty of life of patients with advanced esophageal cancer pain. Guangming J Chin Med 2021; 36: 3692-4.

[32] Zhou L, Li HG, Liu JX. Liu Jiaxiang's  experi­ ence in the syndrome differentiation and treat­ ment of esophageal cancer. Zhejiang J lntegr Tradit Chin West Med 2015; 25: 805-7.

[33] Jia YJ, Fang Y, Yang L, et al. Experience of Shen Shuwen in syndrome differentiation and treat­ ment for esophageal cancer based on "three di­

mensions and six principles". Chin J Inf Tradit

Chin Med 2022; 29: 135-8.

[34] Zhang KK, Gao JQ, Wang XQ. Wang Xiangq 卢experience in treating esophageal cancer. Forum Tradit Chin Med 2022; 37: 48-9.

[35] Han S, Chen X, Wang X, et al. Analysis of WANG xiangqi's  thoughts  on  differentiation and treatment of primary esophageal cancer  based on the concept of "integration of five Zang organs". Clin J Tradit Chin Med 2022; 34: 417-20.

下载信息  [文件大小：7836 KB 下载次数： 次]

点击下载文件:AreviewofresearchprogressonthetraditionalChinesemedicinetreatmentforesophagealcancer.pdf